Switch to:
Cryo-Cell International Inc (OTCPK:CCEL)
EV/EBITDA
8.52 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Cryo-Cell International Inc's enterprise value is $22.42 Mil. Cryo-Cell International Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in May. 2016 was $2.63 Mil. Therefore, Cryo-Cell International Inc's EV/EBITDA ratio for today is 8.52.

CCEL' s EV/EBITDA Range Over the Past 10 Years
Min: -74.6   Max: 177
Current: 8.53

-74.6
177

During the past 13 years, the highest EV/EBITDA Ratio of Cryo-Cell International Inc was 177.00. The lowest was -74.60. And the median was 3.90.

CCEL's EV/EBITDA is ranked higher than
83% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 13.58 vs. CCEL: 8.53 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Cryo-Cell International Inc's stock price is $3.91. Cryo-Cell International Inc's earnings per share for the trailing twelve months (TTM) ended in May. 2016 was $0.85. Therefore, Cryo-Cell International Inc's P/E Ratio for today is 4.60.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Cryo-Cell International Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=22.417/2.631
=8.52

Cryo-Cell International Inc's current Enterprise Value is $22.42 Mil.
Cryo-Cell International Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in May. 2016 was 1.313 (Aug. 2015 ) + -0.15 (Nov. 2015 ) + 0.213 (Feb. 2016 ) + 1.255 (May. 2016 ) = $2.63 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Cryo-Cell International Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=3.91/0.85
=4.60

Cryo-Cell International Inc's share price for today is $3.91.
Cryo-Cell International Inc's Earnings Per Share for the trailing twelve months (TTM) ended in May. 2016 was 0.8 (Aug. 2015 ) + -0.01 (Nov. 2015 ) + -0.01 (Feb. 2016 ) + 0.07 (May. 2016 ) = $0.85.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Cryo-Cell International Inc Annual Data

Nov06Nov07Nov08Nov09Nov10Nov11Nov12Nov13Nov14Nov15
ev2ebitda -56.16-3.601.173.474.14107.90-8.687.9810.7010.48

Cryo-Cell International Inc Quarterly Data

Feb14May14Aug14Nov14Feb15May15Aug15Nov15Feb16May16
ev2ebitda 9.708.219.7210.7010.108.6110.3810.4814.988.64
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK